期刊
GYNECOLOGIC ONCOLOGY REPORTS
卷 21, 期 -, 页码 101-108出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.gore.2017.07.009
关键词
Cervical cancer; Human immunodeficiency virus (HIV); Chemoradiation therapy; Limited resource setting; Cervical cancer screening
资金
- Rwanda Human Resources for Health Program
- Centers for Disease Control
- Global Fund to Fight AIDS, Tuberculosis and Malaria
Since the initial recognition of acquired immunodeficiency syndrome (AIDS) in 1981, an increased burden of cervical cancer was identified among human immunodeficiency virus (HIV)-positive women. Introduction of antiretroviral therapy (ART) decreased risks of opportunistic infections and improved overall survival. HIV-infected women are living longer. Introduction of the human papillomavirus (HPV) vaccine, cervical cancer screening and early diagnosis provide opportunities to reduce cervical cancer associated mortality. In line with 2030 Sustainable Development Goals to reduce mortality from non-communicable diseases, increased efforts need to focus on high burden countries within sub-Saharan Africa (SSA). Despite limitations of resources in SSA, opportunities exist to improve cancer control. This article reviews advancements in cervical cancer control in HIV-positive women.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据